Serum response factor (SRF ) gene expression in avian embryonic muscle lineages plays a central role in activating a-actin gene activity. In early stage HH 6 avian embryos, SRF mRNA expression showed strong localization to the neural groove, primitive streak, lateral plate mesoderm, and Hensen's node, while distinct SRF expression was seen later in the neural folds and the somites by HH stage 8. SRF transcripts appeared in the precardiac splanchnic mesoderm in stage HH 9 embryos and was detected at higher levels in the myocardium, somites, and lateral mesoderm of HH 11 embryos. SRF antibody staining demonstrated significant SRF protein accumulation in the myocardium of the developing heart and the myotomal portion of somites. During primary myogenesis in culture, SRF transcripts and nuclear SRF protein content increased about 40-fold, as primary myoblasts withdrew from the cell cycle, reaching their highest levels prior to the upregulation of the skeletal a-actin gene. A dominant-negative SRF mutant, SRFpm1, which inhibited DNA binding, but not dimerization of monomeric SRF subunits, blocked transcriptional activation of a skeletal a-actin promoter -luciferase reporter gene during myogenesis. Transcriptional blockade was reversed by co-transfections of a wild-type SRF expression vector, but was not rescued by the expression of other myogenic factors, such as MyoD and Mef-2C. Thus, SRF displayed an embryonic expression pattern restricted primarily to striated muscle cell lineages, in which increased mass of nuclear SRF was obligatory for a-actin gene transcription. ᭧
INTRODUCTION
. Mutagenesis studies of skeletal a-actin promoters has demonstrated that CBAR/CArG boxes played a positive role in myogenic inExpression of a-actin genes during early avian (Ruzicka duction (Bergsma et al., 1986; Muscat and Kedes, 1987; and mammalian embryogenesis (SasGrichnik et al., 1988; Chow and Schwartz, 1990) . CArG soon et al., 1989; Sawtell and Lessard, 1989) are among the boxes were also critical to the muscle-specific induction earliest markers for cells committed to cardiac, skeletal, and of the chicken (Quitschke et al., 1989; Moss et al., 1994) , smooth muscle cell lineages. Gene transfer and transgenic Xenopus (Mohun et al., 1989) , and human (Miwa and Kedes, experiments (Petropoulos et al., 1989) have indicated that 1987) cardiac a-actin promoters. In addition to the multiple the capacity for selective genetic expression of the sarcoCArG boxes, the human cardiac a-actin promoter required meric a-actin genes resides mainly within the 5 promoter the combination of an intact MyoD-binding E box and Sp1 and immediate DNA flanking sequences, but can be site for activity in myogenic cells (Sartorelli et al., 1990) . strongly influenced by upstream enhancers (Biben et al., Likewise, the avian cardiac a-actin promoter was regulated 1994) and 3 noncoding regions of these genes (Brennan and through a pair of complex elements composed of E boxes and CArG boxes (French et al., 1989; Moss et al., 1994) . Originally recognized as an essential core element of the 1 To whom correspondence should be addressed at Department c-fos promoter, the serum response element (SRE) was first of Cell Biology, One Baylor Plaza, Houston, TX 77030. Fax: (713) 798-7799. associated with serum responsiveness and the rapid expres-sion of several immediate early genes (Treisman 1985 (Treisman , 1986 , muscle, and to a lesser extent to cell types of neuroectodermal origins (Yu et al., 1992) . Like MEF-2, SRF was virtually 1987; . The highly conserved SRE motif, CC(A/T)6GG, is equivalent to the CBAR (Bergsma et al., absent in endodermal-derived tissues, and SRF protein appeared exclusively during early embryonic heart and skele-1986) and CArG box (Minty and Kedes, 1986 ) motifs, found as multiple copies within the 5 flanking regions of all setal muscle formation. Similarly, avian SRF mRNA and protein were observed to be dramatically increased, as primary quenced vertebrate a-actin genes. Analysis of DNA -protein interactions of this sequence resulted in the identification myoblasts withdrew from the cell cycle and fused, with expression reaching maximal levels in differentiated myoand cloning of serum response factor (SRF) which bound as a dimer and symmetrically contacted various SREs. Cloning tubes. Thus, induction of SRF transcripts appeared prior to the upregulation of the a-actin gene activity during myogenof human (Norman et al., 1988) and Xenopus (Mohun et al., 1991) SRF cDNAs helped to define the DNA-binding/ esis (Hayward and Schwartz, 1986; Hayward et al., 1988) . To investigate if SRF had a primary role in activating the dimerization domain of SRF, termed the MADS box, which shared striking functional homology to yeast transcription skeletal a-actin promoter, a dominant-negative SRF mutant, SRFpm1, which inhibited endogenous SRF DNA-bindfactors MCM1 and Arg 80 (Mueller and Nordheim, 1991) . The amino-terminal basic extension region of the MADS ing activity was observed to block transcriptional activity of SRE containing promoters and the activation of skeletal box was part of the DNA-binding domain, while an immediately adjacent region directed subunit dimerization and rea-actin gene in differentiating myogenic cultures. Our studies demonstrated an SRF gene expression pattern restricted cruitment of accessory factors. Recent studies suggest that MADS box proteins, MCM1, and SRF link genes to signal primarily to striated and smooth muscle cell lineages, in which increased mass of nuclear SRF appeared to be retransduction pathways (Treisman and Ammerer, 1992) . In addition, both MCM1 and SRF are known to interact with quired for a-actin gene transcription. homeodomain proteins (Keleher et al., 1988; Grueneberg et al., 1992; Vershon and Johnson, 1993 ) that can achieve tissue-and cell-type-specific gene expression.
MATERIALS AND METHODS
We observed that SRF binding activity was increased during myogenesis in primary cultured myoblasts, which correIsolation of avian serum response factor cDNA. Avian SRF cDNA was isolated from a Lambda ZAP chicken Embryonic Day lated well with the appearance of the a-actins. Some SREs 17 skeletal muscle cDNA library using the complete coding region displayed myogenic regulatory properties .
of the human SRF cDNA as a homologous probe. Six clones were
The activity of the proximal avian skeletal a-actin SRE was isolated which represented 2300 bp of overlapping sequence. The upregulated during myogenesis when affixed on a minimal primary sequence of this avian SRF was determined by dideoxy promoter (Walsh, 1989) . SRF was shown to be a positive sequencing of Sanger et al. (1977) and deposited in GenBank acting factor for driving a-actin promoter activity, by com-(U50596). The deduced amino acid sequence was highly homolopeting against a negative acting YY1 factor for binding on gous with the amino acid sequences of human (Norman et al., the proximal SRE Gualberto et al., 1992) . (Chambers et al., 1992) SRF and absolutely In addition, Vandromme et al. (1992) (Johansen and Prywes, 1993). teins (RSRF or MEF-2) capable of binding MEF-2 sites,
1988) and Xenopus
The avian skeletal a-actin promoter construct from 0424 to /24
CTA(A/T) 4 TAG, which can be found in the regulatory rebp described previously (Chow and Schwartz, 1990 ) was linked to gions of both nonmuscle and muscle-specific genes (Pollack the firefly luciferase reporter gene (MacLellan et al., 1994) .
and Treisman, 1991; see review Olson et al., 1995) . min centrifugation at 13,000 rpm. The proteins were denatured by acetone at 020ЊC for 90 sec. The coverslips were washed three times in 11 PBS. The coverslips were placed cells side down onto 50 mixing with 4 vol of 6 M guanidine HCl in BC100 and renatured by mixing with 1 vol of BC100 followed by dialysis against BC100.
ml of primary anti-SRF (Manak and Prywes, 1993) antibody (1:1000 dilution) for 45 min at 37ЊC. The cells were washed in 11 PBS Dialyzed proteins were used in electrophoretic mobility shift three times and placed on top of 50 ml of secondary antibody (1:200 assays (EMSA). Samples were incubated for 30 min with gel shift dilution goat anti-rabbit fluorescein-conjugated antibody from Capbuffer (5% glycerol, 50 mM KCl, 1 mM DTT, 1 mM EDTA, 2 mM pel). The cells were washed with 11 PBS and mounted onto slides spermidine, and 0.1 mg/ml herring sperm DNA) and then run at with PBS:glycerol (1:9). Staining was visualized under fluorescence 150 V on 4% PAGE using 0.251 TBE as running buffer. Whole optics with a Zeiss Axiophot microscope. cell extracts and gel shifts from primary myoblast cultures were RNA hybridization assays. Total RNA was obtained from priperformed as described previously . All EMSAs mary myoblast cultures and tissues according to Chomczynski and used the duplexed, 32 P-labeled SRE1 oligonucleotide from the skele- Sacchi (1987) . Total RNA (20 mg) was electrophoresed on a 1% tal a-actin promoter as a probe .
formaldehyde agarose slab gel and transferred onto MSI memIn situ hybridization and immunohistochemistry. Fertilized branes. The chicken avian SRF (1100-bp SmaI fragment), MyoD White Leghorn eggs were obtained from the Department of Poultry (1100-bp PstI/EcoRI fragment), and the skeletal a-actin 3 UTR Science (Texas A & M University) and incubated at 37ЊC. Embryos (Hayward and Schwartz, 1986 ) cDNA probes were labeled by ranwere collected and staged according to ]dCTP and hybridized at 68ЊC in 51 SSC, (1951) . Sectioning and in situ hybridizations were performed as 51 Denhardt's, and 1% SDS for 16 hr. Blots were washed at 68ЊC described by Sundin et al. (1990) . Whole mount hybridizations were under high-stringency conditions, 0.11 SSC and 0.1% SDS. To deperformed as described in Li et al. (1994) with the following exceptermine distribution of SRF transcripts in late stage chicken embrytions. Proteinase K digestions were performed at 10 mg/ml for 10 onic tissues, poly(A) / RNA was collected (Clontech) from Day 18 min, hybridizations and washes were performed at 62ЊC, and no embryos (5 mg/lane) and probed as described above. RNase digestions were performed. A short avian SRF probe (300 Antibodies. Polyclonal antibodies used for immunohistochembp), corresponding to a portion of its 3 UTR, was subcloned into istry, immunofluorescence, and Western analysis in Fig. 4G were pBluescript and linearized to produce antisense 35 S-and digoxydirected against bacterially expressed human SRF (Manak and genin-labeled riboprobes. All immunostainings were performed . SRF epitope-specific antibodies were produced by with an anti-SRF antibody described in Manak and Prywes (1993) immunizing rabbits with a polypeptide specific to the carboxyl at a 1:2000 antibody dilution. et al. (1991) . scribed in Skinner et al. (1987) . The epitope-specific SRF antibody Primary chicken myoblast cultures. Primary embryonic myowas used in tissue and myogenic culture extracts. blast cultures were established as described previously (Lee et al., SRF Western analysis. Dissected tissues and myogenic cul-1992). Cells were seeded at a density of 2 1 10 5 cells per 60-mm tures were rinsed with 11 PBS and homogenized in extraction dish in MEM plus gentamycin with 10% horse serum and 5% chick buffer [0.5 M Tris-HCl (pH 7.0), 8 M urea, 1% SDS, 0.01% PMSF, embryo extract (CEE) in 5% CO 2 at 37ЊC. BudR (5 bromodeoxyuri-1% b-mercaptoethanol]. The extracts were passed through a 21-dine) was added at 30 mM to repress myogenesis. BudR was withgauge needle and cleared for 10 min at 10,000 rpm at 25ЊC. Cell drawn when myoblasts were grown to approximately 70% confluextracts (10 mg/lane) were fractionated on 10% PAGE -SDS slab ence to induce myogenic differentiation. Cells were washed twice gels, transferred onto Immobilon membrane, and probed with afwith 11 PBS and then incubated with MEM plus gentamycin confinity-purified, epitope-specific SRF antibody at a 1:1000 dilution. taining 10% horse serum (HS) and 2% CEE. Cellular samples were Cross-reacting peptides were detected with anti-rabbit IgG alkaline collected every 24 hr following BudR withdrawal for RNA and phosphatase conjugate antibody (1:7500) and developed with niprotein analysis.
troblue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate.
DNA transfection and reporter gene assays. At 48 hr after plat-
The Western blot shown in Fig. 4 was prepared by separating 50 ing, primary cultures were transfected with approximately 1.0 mg mg total protein from hearts that were isolated at the incubated of total plasmid DNA containing the skeletal a-actin promoterstages of development on a 7.5% acrylamide/SDS gel. Following luciferase vector (500 ng), various SRF expression vectors (100 ng), electroblotting to nitrocellulose, the blot was stained with India and pUC18 (400 ng), which served as a carrier, per 60-mm-diameter ink ( Fig. 4F ) and reacted with a 1:2000 dilution of SRF antibody dish. Plasmid DNA was incubated with 4 ml of lipofectamine for (Manak and Prywes, 1993) . Sites of antibody binding were visual-15 min and plated with 1 ml of DMEM for 4 hr. Afterward, cells ized using ECL (Amersham) according to the manufacturer's protowere placed in MEM plus gentamycin with 10% HS and 2% CEE col ( Fig. 4G ). without BudR. Cell extracts were collected and luciferase activity was determined as described in MacLellan et al. (1994) . Transfection experiments were performed in triplicate with two indepen-RESULTS dently isolated sets, and the results were averaged.
Immunofluorescence of myogenic cultures. Primary myoblasts were plated on collagenized glass coverslips in 35-mm dishes at 5
SRF Expression Restricted to Tissues of
1 10 4 cells per plate and cultured as described above. At specific
Mesodermal and Neuroectodermal Origins
timepoints following BudR withdrawal, coverslips were washed in SRF gene expression was evaluated during avian em-11 PBS (phosphate-buffered saline) and adherent cells were fixed in cold methanol for 5 min. The coverslips were placed in cold bryogenesis to determine if SRF gene activity followed a
FIG. 1.
Avian SRF expression at the mRNA, protein, and DNA-binding activity levels was mainly restricted to striated and smooth muscle embryonic tissues. SRF mRNA, protein, and DNA-binding levels were analyzed in tissues isolated from Day 18 chick embryos.
(A) RNA blot of poly(A) / RNA (5 mg/lane) isolated from brain, gizzard, heart, leg muscle, and liver tissues was probed with an 1100-bp cDNA probe corresponding to the C terminal/3 UTR portion of SRF mRNA and with EF1a to standardize RNA loadings. (B) Whole cell protein extracts (10 mg/lane) taken from these tissues were probed by Western blotting with an SRF antibody specific to a epitope specific to the carboxyl region of SRF (NH2-GGHMMYPSPHAVMYA-COOH). SRF was detected with a M r of 49 1 10 3 . (C) SRF DNA-binding activity was tested with whole cell extracts (15 mg) of these tissues by EMSA using the SRE1 of the skeletal a-actin promoter as a probe.
tissue-restricted pattern of expression. The coding region continued to increase in the myocardium through stage 12 embryos prior to its expression in the somites (Ruzicka and downstream of the MADS box served as a specific avian SRF hybridization probe for Northern blot analysis. Two . We wanted to determine if SRF mRNA and protein expression patterns were also locally restricted mRNA species that corresponded to 3.5-and 2.5-kb SRF mRNA ( Fig. 1A) were detected from RNA extracted from to early embryonic cardiac and skeletal muscle cell lineages. SRF mRNA expression was detected as early as stage 4 Day 18 embryonic tissues. These multiple SRF mRNAs were due to differential 3 polyadenylation (data not shown), throughout the epiblast and in the blood islands, which are mesodermal cells giving rise to the hematopoetic lineages as shown for human SRF mRNA (Norman et al., 1988) . SRF mRNA was enriched in cardiac, skeletal, and enteric involved in erythropoeisis and angiogenesis ( Fig. 2A) . Such early presence of SRF mRNA was suggestive of a maternally smooth muscle tissues and to a lesser extent in neuroectoderm-derived brain tissue (Fig. 1A) . SRF transcripts were stored transcript. In a stage 6 embryo, SRF was widely expressed with strong localization to the neural groove, the virtually undetectable in endodermal-derived liver tissue. Similarly, Western protein blot analysis revealed a higher primitive streak, the lateral plate mesoderm, and the underlying endoderm (Fig. 3A) . Figures 2B and 2C showed translevel of SRF protein in leg muscle, gizzard, and cardiac tissue extracts than in brain (Fig. 1B) , while SRF protein was verse sections through the region anterior to Hensen's node (see Fig. 3A for plane of sectioning) and illustrate strong barely detected in liver tissue. SRF DNA-binding activity, evaluated by EMSA with a labeled skeletal a-actin proximal SRF expression in the neural plate and lower expression in the underlying mesendoderm (Fig. 2C ). More posterior SRE1 double-stranded oligonucleotide probe, also displayed the highest binding activity in extracts collected from cartransverse sections revealed SRF transcripts concentrated diac and skeletal muscle tissues, lower binding activity in in the primitive streak (Fig. 2D ). In the posterior most dobrain extracts, and no binding activity in liver extracts (Fig. main of the embryo, SRF expression was low and apparently 1C). Thus, SRF gene expression pattern during late stage uniform (Fig. 2E ). As can be seen in Fig. 3A , there was an avian embryogenesis was restricted to striated and smooth enrichment of SRF mRNA on the right side of Hensen's muscle tissues and to a lesser extent to tissues of neuroecnode, a region which also expressed activin receptor IIa todermal origins.
( Stern et al., 1995) . At stage 8, distinct expression was seen in the neural folds representing the prospective hind-, mid-, and posterior half of the forebrain (Fig. 3B ). At this
Developmental Expression of SRF
stage, the somites also expressed the SRF gene. Regions posterior to the somites (not shown) expressed SRF in a During avian embryogenesis, expression of sarcomeric apattern seen in earlier stages (Fig. 3A) . By stage 11, SRF was actin transcripts served as an early marker for differentiaseen in the neuroectoderm of the brain and the neural tube tion of cardiac and skeletal muscle cell lineages. Cardiac a- and in the developing heart (Fig. 3C ). actin mRNA was first detected in HH stage 9 embryos in the Transverse sections revealed high levels of SRF expression thickened splanchnic mesoderm which forms the proximal wall of the amniocardiac vesicle. Cardiac a-actin expression in the myocardium and the pharyngeal foregut endoderm ( Fig. 2F ) , coincident with cardiac a-actin expression (Ruzriorly in the somites and the lateral plate mesoderm (Figs. 2G -2J and 3E). Both, transverse sections (Figs. 2I and 2J) icka and Schwartz, 1988). SRF was also detected at high levels in the splanchnic mesoderm (Fig. 2G ) and more posteas well as whole mounts (Fig. 3E ) illustrated a significant difference in the level of SRF transcripts in somites and presomitic mesoderm. Note the absence of SRF expression in dorsal surface ectoderm and also the lack of specific hybridization in a stage 12 embryo hybridized with an SRF sense riboprobe shown in Fig. 3F . In contrast to SRF transcripts, the SRF protein appeared predominantly during cardiac morphogenesis in the avian embryo. Immunoperoxidase staining was performed with an antibody directed against bacterially expressed human SRF. SRF protein was abundant in the fusing paired primordia (Fig. 4A) and myocardium (Figs. 4B -4D ) of the developing heart. The HH stage 15 section (Fig. 4D) , which transected a pair of somites, also showed SRF protein localized to the somites. Lower levels of SRF was also detected in the pharyngeal foregut (Fig. 4D ). Higher magnification of the somites in Fig. 4D showed SRF protein localized to the myotomal portion of the anterior somites (Fig. 4E) . Interestingly, while SRF mRNA was abundant throughout the neural tube (Fig. 2) , SRF protein was detected only at relatively low levels in the neural tube at early embryonic stages, suggesting that translational regulation of SRF mRNA may further restrict SRF expression activity during early embry- troblotted proteins in Fig. 4F showed approximate equal loadings of proteins that were extracted from isolated hearts. The results of these experiments demonstrated that SRF gene expression was developmentally regulated and largely confined to the cardiac and skeletal muscle cell linblasts withdrew from the cell cycle, aligned, and fused into multinucleated myotubes. SRF mRNA levels continued to eages, consistent with the developmental specific expression of a-actin genes in the avian embryo.
increase, reaching the highest levels in differentiated myotubes (84 hr following BudR withdrawal). The upregulation of SRF transcripts preceded the appearance of skeletal a-
SRF Expression Regulated during Primary Avian
actin gene transcripts, which were first detected in 60-hr Myogenesis myotubes, and paralleled the expression of the skeletal aactin gene following fusion. We wanted to determine the temporal and spatial expression pattern of SRF gene activity during primary avian myoExpression and intracellular localization of SRF protein was analyzed by immunoblotting (Fig. 6A) . and immunogenesis in culture, since SRF was shown to be expressed primarily in late stage embryonic muscle (Fig. 1 ) and in fluorescence staining (Figs. 6B -6D ) of primary chick myoblast cultures using two polyclonal antibodies; one raised earlier embryonic somites (Figs. 2H -2I and 4D -4E). Because dissociated chick primary myoblasts rapidly withagainst the SRF C-terminal specific epitope (see Materials and Methods) and the other raised against bacterially exdraw from the cell cycle and fuse following plating, the entry to the differentiated state was inhibited by allowing pressed human SRF (Manak and Prywes, 1993) . To exclude possible cross-reactivity of antibody reaction with other remyoblasts to cycle over 72 hr in the presence of BudR; (Schwartz and Rothblum, 1981) . Replicating myoblasts lated MADS box factors, a monospecific SRF antibody was produced against a 15-amino-acid polypeptide epitope found were then released from the BudR differentiation block and allowed to progress through myoblast fusion and terminal only in the carboxyl region of SRF corresponding to amino acid numbers 405-418 in the human SRF sequence. This differentiation. Muscle-specific MyoD transcripts appeared earliest and maximally within 12 hr following BudR withregion was absolutely conserved in avian, Xenopus, and human SRF. Whole cell protein extracts, collected from pridrawal and then gradually declined during fusion, between 36 and 60 hr later (Fig. 5) . SRF mRNA transcripts were not mary myoblast cultures at developmental timepoints, were probed with the affinity-purified SRF antibody. Similar to evident in BudR replicating myoblasts. SRF message was first detected 36 hr following BudR withdrawal, when myothe induction of SRF mRNA, SRF protein levels, barely de-ated myotubes were estimated to be 40-fold higher than the levels detected in replicating myoblasts. Immunofluorescence staining of myogenic cultures showed low levels of nonnuclear SRF fluorescence, consistent with the downregulation of SRF gene activity in replicating BudR-treated myoblasts (Fig. 6B) . During myoblast fusion, SRF staining was enhanced in the cytoplasm and along the elongated filopodia which connect the fusing myoblasts (Fig. 6C) . SRF immunostaining became localized to nuclei of fusing, postreplicative myoblasts and differentiated myotubes (Figs. 6C and 6D), correlating well with the rapid increase in a-actin transcription. These results indicated that SRF expression was upregulated during the withdrawal from the cell cycle and the transport of SRF to myotube nuclei might be part of a myogenic-regulated mechanism that precedes the expression of skeletal a-actin.
SRF Dominant-Negative Mutant Forms Dimers, but Does Not Bind DNA
We evaluated the potency of an SRF dominant-negative mutant to block endogenous SRF DNA-binding activity to determine if the skeletal a-actin promoter was a direct target for SRF activity. The SRFpm1 mutant has three point mutations in the DNA binding domain of SRF in which a cluster of amino acids at positions Arg 143 , Lys 145 , and Leu 146 of the human SRF that make critical base contacts were converted to the neutral amino acids isoleucine, alanine, and glycine respectively (Fig. 7A ). These mutations leave the SRF dimerization domain intact. Thus, SRFpm1 would still foster SRF dimerization between mutant and wildtype SRF monomers, while the binding of the heterodimer to its DNA-binding target would be compromised (Kim et al., 1994) . Mobility shift binding studies were performed using strategy of denaturation and co-renaturation of the polypeptides to evaluate this dominant negative mutant. As shown in Fig. 6B , bacterially expressed SRFpm1 mutant was incapable of binding to an SRE containing oligonucleotide duplex, whereas the full-length SRF1-508 (B1; band by homodimer of wild-type SRF ) and a C-terminal domain truncated SRF1-244 (B3; band by homodimer of SRF1-244 ), which both contain intact MADS box sequences, bound the SRE. To odimers (B2) which lost most of its DNA-binding activity ( 1 6 to 1 9 activity of wild-type SRF ). SRFpm1 homodimers showed no detectable DNA-binding activity (B1).
To determine if the SRFpm1 mutant was capable of tected in replicating myoblasts, increased approximately 10-fold during myoblast fusion, 48 hr after BudR withinhibiting endogenous SRF DNA binding activity in primary myoblasts, SRFpm1, wild-type SRF, and the pCGN drawal. The highest levels of SRF in terminally differenti- -508aa) , SRFpm1, SRF(1-244aa)] were mixed as described under Materials and Methods and were analyzed by gel-mobility shift assay using the SRE1 of the skeletal a-actin promoter as a probe. Homodimers of SRF(1-508aa), (B1), heterodimers between SRF(1-244aa) and SRF(1-508aa) or SRFpm 1 (B2), and homodimers of SRF(1-244aa) (B3) gave distinct EMSA shifts. Note the reduction of binding activity of heterodimers (B2) when SRFpm1 was mixed with SRF(1-244aa). This binding activity was in sharp contrast to the binding activity detected when SRF(1-508aa) was mixed with SRF(1-244). (C) Western blot expression of SRF constructs in transient transfected myoblast cultures. The vector control (pCGN), wild-type SRF (pSRF), and the SRF dominant-negative mutant (SRFpm1) were transfected into primary myoblast cultures. Whole cell extracts were collected and probed with the anti-HA antibody which recognized the flu epitope. (D) Expression of the SRFpm1 mutant reduced endogenous SRF DNA-binding activity. Extracts collected in (C) were subjected to band shift analysis using the SRE1 of the skeletal a-actin promoter as a probe. All extracts were collected 72 hr following transfection, from myotubes. Various amounts of whole cell protein extracts were added to the shift reactions. Lanes 1, 5, and 9 contained 0 mg protein extract. Lanes 2, 6, and 10 contained 1.0 mg protein extract. Lanes 3, 7, and 11 contained 2.5 mg protein extract. Lanes 4, 8, and 12 contained 5.0 mg protein extract. plasmid vector were transiently transfected into primary sis showed the SRFpm1 mutant was able to reduce the DNA-binding activity of endogenous SRF (Fig. 7D) . Cells chick myoblast cultures. Expression of the SRF constructs was driven by the constitutive CMV promoter.
transiently transfected with SRFpm1 showed about a 50% reduction of SRF binding compared to cells transfected This vector also encoded the HA flu epitope at the amino terminus to allow detection of expression of the with the pCGN vector and about a 75% reduction in SRF binding compared to cells transfected with wild-type SRF transfected proteins. Whole cell extracts were collected 72 hr after transfection. Blots probed with the anti-HA (pSRF ), as determined by Betagen scanning. Since these constructs were transiently transfected into primary epitope antiserum showed the transfected myotubes expressed the wild-type SRF and SRFpm1 constructs (Fig. myoblast cultures, full inhibition of SRF DNA-binding activity was not detected. Nevertheless, these results in-7C). These extracts were then used for band shift analysis to determine if the SRFpm1 mutant can affect DNA binddicated that the SRFpm1 dominant-negative mutant, when transfected into primary myoblast cultures, showed ing of endogenous cellular SRF. Using the SRE1 from the skeletal a-actin promoter as a probe, DNA-binding analya significant reduction in endogenous SRF DNA-binding activity, thus serving as a useful tool to study the functional activity of SRF during myogenesis.
SRF pmI Blocked SRE-Dependent Skeletal a-Actin Promoter Activity during Myogenesis
The specificity of the SRFpm1 mutant was evaluated in vivo, by cotransfection experiments with a variety of different cis-regulatory elements linked to luciferase reporter genes in primary chicken myoblasts (Fig. 8A) . BudR-treated replicating myoblasts were cotransfected with reporter gene constructs and wild-type SRF, pCGN, or SRFpm1 expression vectors. Extracts were collected 72 hr following BudR withdrawal and assayed for luciferase activity. We observed that SRFpm1 inhibited the activity of the skeletal a-actin promoter and a minimal SRE promoter (skSRE1), but did not effect synthetic promoters containing multiple E boxes or MCAT (TEF-1)-binding sites. The SRFpm1 mutant did not display inhibitory activity on a promoter containing a pair of MEF-2-binding sites (data not shown). These results suggested that the SRFpm1 inhibitory activity was limited to SRE cis-elements and that a single SRE cis-element was sufficient for SRFpm1 inhibitory activity. Evidently, this mutant did not discriminate between SREs from either muscle a-actin (skSRE1) or c-fos promoter (data not shown) and exerted its inhibitory activity on intact SREs. We did not observe a significant induction in skeletal a-actin lucif-
FIG. 8.
The SRFpm1 mutant blocked the activity of SRE conerase activity with cotransfected pSRF probably due to a taining promoters and the upregulation of the skeletal a-actin prosaturating effect seen with the overexpression of wild-type moter during myogenesis. All promoters were linked to a minimal SRF . taining promoters, skeletal a-actin promoter, and skeletal a-actin SRE1 (skSRE1). SRFpm1 did not affect the activity of E box or The SRFpm1 mutant was used to block the endogenous SRF BudR inhibition. The other SRF mutant (SRF 1-338 ) provided about a 75% reduction in a-actin promoter activity. As shown in Fig. 7B , skeletal a-actin promoter activity was induced over 50-fold throughout terminal differentiation as In order to determine if SRFpm1 specifically inhibited SRF activity during myogenesis, wild-type SRF (pSRF) was measured by luciferase activity in cells transfected with the same amount of pCGN vector or wild-type SRF.
cotransfected with the SRFpm1 mutant and tested for the neuronal tissues and virtually undetectable levels of SRF in liver tissue of late stage avian embryos (Fig. 1) . In addition, we observed highly expressed levels of SRF mRNA in precardiac splanchnic mesoderm and dorsal somitic mesoderm (Figs. 2 -3 ). SRF protein was also shown to be selectively expressed in the myocardium during heart morphogenesis and in the myotomal segment of the anterior somites in avian embryos (Fig. 4) . Mohun et al. (1991) also found an accumulation of Xenopus embryonic SRF transcripts following gastrulation, but the distribution of SRF protein in embryonic tissues was not examined. Thus, high levels of SRF expression appears to coincide with the transition of going through gastrulation and neurulation when the expression of cardiac, skeletal, and smooth muscle a-actins appear as early markers for terminal striated and smooth showed that SRF mRNA containing the 5 UTR was inefficiently translated in reticulocyte lysate system (Norman et al., 1988) . A number of other genes, such as TGF-b, c-myc, and nanos, have also been shown to be translationally reguability of SRF to rescue the SRFpm1-inhibited skeletal alated by long 5 UTR's (Arrick et al., 1991; Parkin et al., actin promoter activity. BudR-treated myoblasts were co-1985) or 3 UTRs (Wharton and Struhl, 1991) . MEF2A has transfected with SRFpm1 and increasing doses of pSRF, also been shown to be translationally regulated when vascu-MEF-2, or MyoD expression vector plasmid DNA. A luciferlar smooth muscle cells were stimulated with mitogens ase gene driven by the skeletal a-actin promoter was used (Suzuki et al., 1995) . Perhaps like MEF2A which also conas a reporter construct. Myoblasts were collected and astains long 5 and 3 UTRs, SRF may also contain sequences sayed for luciferase activity 36 hr following BudR withrequired for translational control. drawal. As shown in Fig. 9 , myoblasts cotransfected with Expression of SRF in the early heart and skeletal muscle pSRF and SRFpm1 displayed 4-to 5-fold restoration of skeleof the developing chick embryo suggests that SRF may be tal a-actin promoter activity compared to myoblasts a critical factor required for proper heart and skeletal muscle transfected with SRFpm1 alone. Cotransfections of MEF-2 formation. Early expression of SRF in the developing myoor MyoD with SRFpm1 did not significantly recover skeletal cardium is similar to the expression of Nkx-2.5/Csx in the a-actin promoter activity, which suggested that SRFpm1 mouse. Nkx-2.5 is a cardiac-specific homeobox gene related displayed a rather exclusive SRF inhibitory activity. These to the Drosophila tinman gene, required for the elaboration results strongly support the role of SRF as a myogenic-reguof early mesoderm and heart primordia (Azpiazu and Frasch, lated and restricted transcription factor, required for the 1993; Bodmer 1993). Nkx-2.5 is expressed in the myocardioexpression of skeletal a-actin, a specific marker of terminal genic progenitor cells and the myocardium in the mouse myogenic differentiation.
and chicken (Komuro and Izumo, 1993; Lints et al., 1993; Schultheiss et al., 1995) . Recent studies from our laboratory indicate that Nkx-2.5 physical association with SRF can DISCUSSION drive the expression of the cardiac a-actin promoter in nonmyogenic fibroblasts (Chen et al., 1996) . The recent homozygous knockout of Nkx-2.5, which caused embryonic leWe observed differential SRF gene expression during avian embryogenesis. Assays of SRF mRNA, protein, and thality, probably elicited by the failure to fold the heart tube into a chambered heart and by the lack of myocardial cell DNA-binding activity indicated enrichment of SRF gene products in striated and smooth muscle tissues. By these expansion associated with ventricular trabeculation , was suggestive of having an important role in criteria, lower but significant SRF levels were detected in cardiogenesis. The coexpression of SRF and Nkx-2.5 and ment of SRF in some nonmyogenic cell types was below detection in our assays, we cannot eliminate the possibility perhaps other related Nkx homeodomain members expressed in cardiac progenitor cells may therefore be responat this time, that growth factor-induced SRF complexes with Phox 1 and Elk-1 would be insufficient to mediate sible for the early expression of cardiac a-actin in the embryo.
serum-inducible events. For example, SRF-binding activity was shown to be approximately two orders of magnitude The expression of SRF mRNA in the avian embryo is similar to the expression pattern of the related MADS box greater in cardiac myocytes than in HeLa cells, the primary cell system used to study SRF-dependent growth factor recontaining MEF-2 genes. Like SRF, MEF-2 is preferentially expressed in human heart and skeletal muscle tissue (Yu et sponse (MacLellan et al., 1994) . Thus, even trace amounts of SRF appear to be sufficient to mediate serum inducibility al., 1992). During mouse embryogenesis, MEF-2C is activated early in the anterior lateral plate mesoderm prior to in most cell types. However, our observations clearly support a tissue-restricted expression pattern of SRF gene activthe expression of muscle-specific structural genes. MEF-2A, C, and D are detected in the myocardium and in the soity during early and late avian embryogenesis. The recent elucidation of the X-ray crystal structure of mites, suggesting an important role for SRF and MEF-2 in developmental myogenic differentiation (Edumundson et the SRF core bound to DNA provides an explanation for the inhibitory activity of the SRF mutant, SRFpm1 (Pellegrini al., 1994) . The Drosophila homolog of MEF-2, d-mef2, is expressed throughout the somatic and visceral mesoderm et al., 1995) . A novel DNA-binding motif, a coiled-coil formed by the MADS box a1 helices (aa153 -aa179), lies following gastrulation, and in the heart. d-mef2 mutant embryos show a dramatic absence of differentiated somatic, parallel and on top of a narrow DNA minor groove making contacts with the phosphate backbone on an SRE half site, cardiac, and visceral muscle fibers (Lily et al., 1995; Bour et al., 1995) . The recent demonstration that MEF2 and myowhile within an unstructured N-terminal extension from the aI helix (aa132 -152aa) the Arg 143 made critical base genic basic helix-loop-helix proteins associate on DNA raises the possibility that these two classes of myogenic contacts in the minor groove. Therefore, mutating the Arg 143 residue to a neutral amino acid weakened the critical transcription factors collaborate to induce muscle-specific transcription of MEF-2-dependent genes (Molkentin et al., base contacts required for DNA binding, but did not participate in the dimerization of SRF monomers, which occurs 1995). Therefore, a common property of these related MADS box proteins could be their ability to cooperate with other above the aI helix by a structure composed of two b-sheets in the monomer that interact with the same unit in its transcriptional regulators to control gene expression of downstream target genes.
partner. We investigated the role of an SRF mutant, SRFpm1, as a specific reagent to test the role of SRF in Concordant with its role as a positive regulator of a-actin genes, we detected a significant increase in SRF transcripts directing skeletal a-actin promoter activity. Analogous to naturally occurring dominant-negative mutants, such as Id and protein mass during primary myogenesis in culture correlating with the induction of skeletal a-actin (Figs. 5 and (Benezra et al., 1990) , that form inactive heterodimers with monomeric bHLH factors, we showed in Fig. 7 that SRFpm1 6) and cardiac a-actin (data not shown). SRF expression was repressed in replicating myoblasts, while SRF mRNA and inhibited DNA binding to a great extent, while still allowing for effective dimerization with wild-type SRF, thus protein accumulated during the progression from primary myoblast cultures to postdifferentiated myotubes. SRF exresulting in heterodimers incapable of efficient DNA binding. SRFpm1 displayed significant dominant-negative activpression increased to its highest levels in postreplicative myotubes, being localized to the nucleus, which preceded ity by inhibiting SRE containing promoter activity without direct DNA binding, thus demonstrating a real requirement the induction of skeletal a-actin expression during myogenic differentiation. Our results contrast those of Van- for the transfactor. In contradistinction, C-terminal activation domain SRF deletion mutants inhibited downstream dromme et al. (1992) in which no significant changes in SRF levels were detected in the rat L6 and mouse C2C12 targets such as skeletal a-actin promoters (Fig. 7B ) by direct DNA binding to any available SRE, thus acting as a de facto myogenic cell lines during myogenesis in culture. This discrepancy may be due to inherent differences between prirepressor. We observed interference with endogenous SRFbinding activity following efficient transfection assays of mary cell cultures and highly passaged established cell lines. For example, C 2 C 12 cell were shown to poorly express replicating primary myoblasts with SRFpm1 (Fig. 7D) . SRF does not associate with other MADS box family members skeletal a-actin gene activity in comparison to levels measured in primary myoblast cultures (Bains et al., 1984 ; Blau such as MEF-2/RSRF (Pollack and Treisman, 1991); accordingly, we did not observe SRFpm1 inhibitory activity on a et al., 1985) , and passaged C 2 C 12 cell lines were incapable of expressing a full complement of myogenic bHLH factors minimal MEF-2 promoter (data not shown). Dominant-negative SRF activity might also be complethat are found during embryonic primary myogenesis in culture. Our observations that SRF gene activity displayed mented by the formation of nonfunctional SRF heterodimers or SRFpm1 homodimers that could compete with endogselective enrichment in embryonic myocardial-, skeletal-, and smooth muscle-derived cell types should dispel any enous SRF for the binding of relevant accessory factors or might even provide nonfunctional targets for phosphorylanotion that SRF is a general factor with a limited range of expression (Norman et al., 1988) . Although the measuretion events. Coexpression of SRFpm1 with reporter gene constructs maximally repressed the activity of the skeletal activator or repressor of transcription depending upon the identity of an associated factor, such as the interaction bea-actin promoter throughout myogenesis, supporting the role of SRF as a differentiation factor in muscle cells. The tween MCM1 and MAT a2 (Keleher et al., 1989) , another homeodomain factor, which is critical for the establishment inhibitory activity by SRFpm1 was shown to be rescued only by the addition of SRF, indicating that SRFpm1 speof cell identity (the a and a-specific genes) in yeast. Hypothetically, the increased levels of SRF in nonreplicating cifically inhibited SRF activity (Fig. 9) . Similarly, we recently observed that stable transfections of Sol 8 and C 2 C 12 skeletal myoblasts and cardiac myocytes might repress the nonmyogenic c-fos promoter through forming nonproducmyogenic cell lines with SRFpm1 inhibited myoblast fusion and postreplicative myogenic differentiation. SRFpm1-tive complexes through its SRE that compete off serum growth factor induced SRF/Elk-1/Phox1 complexes transfected cells were unable to express myogenin and blocked skeletal a-actin gene activity, as in the findings (Grueneberg et al., 1994) . Therefore, large changes in SRF cellular content might be part of a mechanism that mediof Vandromme et al. (1992) in which microinjected SRF antibodies blocked C2C12 myogenic differentiation. In adates accessory factor interactions that may either activate or repress transcription of various target genes. As demondition, expression of genes involved in cellular proliferation did not appear to be affected by the SRF mutant (data not strated by modest co-transactivation of the skeletal a-actin promoter as shown in Fig. 8 , and by inshown). These results further support the notion that SRF has an integral role during myogenic differentiation.
creased SRF levels alone are not totally sufficient for driving the a-actin gene activity. Therefore, we predict that the Although it is generally assumed that SRF serves a role as a constitutive factor during its association with accessory appearance of a myogenic coaccessory protein factor(s) might play an important role in the muscle-specific expresfactors, we have shown that SRF-binding activity actually increased dramatically following the ending of the cell replision of skeletal a-actin that will associate with the increased nuclear content of SRF during myogenesis. cation primarily due to change in the cellular content of SRF in primary myoblasts (Lee and Schwartz, 1992 
